ASCO Honors PCF’s Howard Soule with Prestigious Partners in Progress Award
June 3, 2013 -- The American Society of Clinical Oncology today presented Howard H. Soule, PhD, Chief Scientist and executive vice president of the Prostate Cancer Foundation (PCF), with its prestigious Partners in Progress Award during ASCO’s 2013 Annual Meeting in Chicago today.
In all, seventeen American leaders in oncology were recognized for their dedication to improving the lives of people living with cancer. Through its Annual Special Awards Program, ASCO recognizes researchers, patient advocates, and leaders of the global oncology community who, through their work, have made significant contributions to enhancing cancer care. The recipients of ASCO’s highest honor collectively represent significant strides in cancer treatment and leadership in the oncology community.
“The recipients of this year’s awards are the past, present and future of our field,” said Michael P. Link, MD, Immediate Past President of ASCO and Chair of the Special Awards Selection Committee. “They have contributed tremendously to the body of work that is improving the treatment and care of people with cancer. It is our honor to bestow these awards upon them.”
Other 2013 awardees include the director of the Office of Hematology and Oncology Products in the Center for Drug Evaluation and Research of the U.S. Food and Drug Administration and a scientist belonging to the group that performed the first genome-wide association study of BRCA2 breast cancer. Also honored was Charles L. Sawyers, a long-time member of PCF’s global research enterprise.
“It is hard to think of a more deserving individual for this award than Dr. Soule,” said Jonathan W. Simons, MD, president and CEO of the Prostate Cancer Foundation. “In his 16 years with PCF, Dr. Soule has spearheaded our efforts to build a global research enterprise for prostate cancer that is accelerating discovery and breakthroughs for delivering better treatments for patients. We and millions of patients and their families are grateful to Dr. Soule for his work and outstanding accomplishments.”
Dr. Soule’s role in the Prostate Cancer Foundation has greatly contributed to the Foundation’s success in accelerating international research and in increasing public awareness of the disease. He coordinates global academic, government, and biopharmaceutical sector research activity and is responsible for the implementation of the PCF's global research strategies. Dr. Soule is a senior fellow of the Milken Institute, a nonprofit, nonpartisan think tank and is also a member of the Department of Defense Prostate Cancer Research Program Integration Panel and is a senior advisor to medical research programs at the Milken Family Foundation and the Melanoma Research Alliance.
Facebook Users: Please note that your comment or profile will not be posted to this page, or to Facebook, until you click the “Comment” button. If you do not want your comment to be posted to Facebook, please uncheck the “Post to Facebook” checkbox.